Natco Pharma Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

02:54 PM, 3rd Feb 2026

Natco Receives Tentative Approval for Erdafitinib Tables (generic of Balversa) from the United States Food and Drug Administration (U.S.FDA)